@techcrunch.com 23 days ago
This Swedish startup wants to reduce the cost, and controversy, around stem cells production
@tech.eu 2 years ago
Medication intelligence platform Synapse Medicine raises €25 million
@techcrunch.com 2 years ago
Rani Therapeutics’ $73M IPO will fund upcoming clinical trials
@techcrunch.com 3 years ago
Vibrant raises $7.5M for a drug-free mechanical pill to treat constipation
@xconomy.com 3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com 3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com 3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com 3 years ago
Goldfinch Raises $100M for Kidney Drug Studies Now, Perhaps an IPO Later
@tech.eu 3 years ago
Belgian startup BioStrand raises €2 million to disrupt genetic data analysis
@xconomy.com 3 years ago
Lyra Therapeutics IPO Raises $56M for Tests of Tech for Runny Noses
@xconomy.com 4 years ago
With Bristol and Otsuka on Board, LSP Raises $620M EU Life Sciences Fund
@xconomy.com 4 years ago
EnClear Therapies Nets $10M to Test Neuro Disease ‘Dialysis’ Device
@techcrunch.com 4 years ago
UK biotech startup Mogrify injects $16M to get novel cell therapies to market soon
@xconomy.com 4 years ago
Bardy Diagnostics to Ramp Up Cardiac Monitor Sales With $35M Raise
@xconomy.com 5 years ago
Biolinq Adds $4.75M to Advance Glucose Monitoring Biosensor Patch
@xconomy.com 5 years ago
Magnolia Medical Captures $20M to Reduce Blood Culture Contamination
@xconomy.com 5 years ago
RiverVest Venture Closes $184M Fund for Backing Healthcare Ventures
@xconomy.com 5 years ago
TP Therapeutics Names New CEO, Gets $80M More For Cancer Drug Push
@xconomy.com 5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@xconomy.com 5 years ago
IPO Wave Rolls On as Five Life Science Firms Haul in $651M
@xconomy.com 5 years ago
OncoNano, Maker of Tumor Imaging Technology, Raises $11.7 Million
@techcrunch.com 6 years ago
Fractyl Labs raises $44 million in Series D to develop a treatment for type 2 diabetes